Evotec Signs Two Deals With Sanofi | Chemical & Engineering News
Volume 93 Issue 32 | p. 37 | Concentrates
Issue Date: August 17, 2015

Evotec Signs Two Deals With Sanofi

Department: Business
Keywords: contract research, drug discovery

The German contract research firm Evotec has formed two drug discovery agreements with Sanofi. In the first, Evotec and Apeiron Biologics are joining with Sanofi to develop small-molecule-based cancer immunotherapies. Evotec and Apeiron will get undisclosed research payments and could reap milestone payments of more than $200 million. In the second, Evotec and Sanofi will combine their know-how in human β cells to identify β-cell-active small molecules and biologics that could treat diabetes. Evotec will get $3 million up front plus milestones.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment